Parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections
US6264945A · kind A · utility
47Cited by
4References
23Claims
0Family size
Inventors
Key dates
| Filing date | Jan 14, 2000 |
| Grant date | Jul 24, 2001 |
| Priority date | — |
| Expiry date | Jan 14, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y302/01017
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention discloses a method and composition for the treatment of bacterial infections by the parenteral introduction of at least one lytic enzyme produced by a bacteria infected with a bacteriophage specific for that bacteria and an appropriate carrier for delivering the lytic enzyme into a patient. The injection can be done intramuscularly, subcutaneously, or intravenously.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.